BRD BRD - Groupe Société Générale S.A.
BRD - Groupe Société Générale S.A. provides a range of banking and financial services to corporates and individuals in Romania. It operates in Retail and Non-Retail segments. The company offers savings, deposits, and current accounts; term deposits; personal, housing, youth, refinancing, and investment loans, as well as agriculture loans; credit and debit cards; and transfer, investments and insurance services. It also offers card processing, and cash collection services; global transaction banking; corporate loans; mergers and acquisitions; treasury; and securities services. In addition, the company provides internet and mobile banking, payments, and custody; letter of guarantee; financing; and foreign exchange services. The company was founded in 1990 and is based in Bucharest, Romania. BRD - Groupe Société Générale S.A. is a subsidiary of Société Générale Société anonyme.…
Industry Peers
Banks - RegionalKey Statistics
About BRD - Groupe Société Générale (BVB: BRD)
›
BRD - Groupe Société Générale (BVB: BRD) is listed on Bucharest Stock Exchange, where its shares trade in RON. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 4,752 employees.
The shares were at 31.90 RON on 19 November 2026, up 51.2% over 52 weeks. Its 52-week range is 21.10 RON to 39.25 RON: the price is 18.7% below the high and 51.2% above the low.
At a market capitalisation of 22.23B RON, it trades at 14.2 times trailing earnings and 15.3 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.6, a premium of 35% for BRD. It pays a dividend yielding 3.38% (it pays out 48% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
BRD - Groupe Société Générale reports return on equity of 14.6%, an operating margin of 46.8% and flat revenue year over year.
It holds more cash than debt, a net cash position of 6.67B RON. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 6 analysts cover the stock; their mean price target of 25.98 RON is 18.6% below the current price. The next earnings report is expected on 4 February 2027.